To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02663908
Title A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Acronym PRONOUNCE
Recruitment Terminated
Gender male
Phase Phase III
Variant Requirements No
Sponsors Ferring Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | SVK | POL | GRC | GBR | FRA | FIN | DEU | CZE | CAN


No variant requirements are available.